MT-201-GBM
N/A
Report date: 2022/12/27 16:24:11
Base Information
Drug NameMT-201-GBM
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDuke UniversityMyeloid Therapeutics Inc
China Registration ClassN/A
Develop Information
Active CompaniesDuke University
Inactive CompaniesNational Cancer Institute
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A